- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
National Health Service, England
Made
3rd March 2011
Laid before Parliament
11th March 2011
Coming into force
20th April 2011
The Secretary of State for Health makes these Regulations in exercise of the powers conferred by sections 88 and 272(7) and (8) of the National Health Service Act 2006(1).
1.—(1) These Regulations may be cited as the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Amendment) Regulations 2011 and come into force on 20th April 2011.
(2) These Regulations apply in relation to England.
2.—(1) Schedule 2 (drugs, medicines and other substances that may be ordered only in certain circumstances) to the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004(2) is amended as follows.
(2) For the entry for “Oseltamivir (Tamiflu)” which is referred to in column 1, in the part which relates to “treatment of influenza” (as mentioned in column 3) in column 2, in paragraph (1), insert “or who is aged under 65 years and is at risk of developing medical complications from influenza,” after “aged 65 years or over,”.
(3) For the entry for “Zanamivir (Relenza)” which is referred to in column 1, in the part which relates to “treatment of influenza” (as mentioned in column 3) in column 2, in paragraph (1), insert “or who is aged under 65 years and is at risk of developing medical complications from influenza,” after “aged 65 years or over,”.
Signed by authority of the Secretary of State for Health.
Earl Howe
Parliamentary Under-Secretary of State,
Department of Health
3rd March 2011
(This note is not part of the Regulations)
These Regulations amend the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 (S.I. 2004/629).
Regulation 2 amends Schedule 2 so that the description of persons in respect of which Oseltamivir and Zanamivir may in certain circumstances be ordered is widened to include those who are under 65 years of age, who are not pregnant, nor considered to be at clinical risk, but who are considered to be at risk of developing complications from the symptoms of influenza.
A full impact assessment has not been produced for the instrument as no impact on the private or voluntary sector is foreseen.
2006 c.41. See section 275(1) of the Act for the definitions of “prescribed” and “regulations” which are relevant to the powers being exercised in the making of these Regulations.
S.I. 2004/629. Relevant amendments were made by S.I. 2004/3215, 2009/2230 and 2010/2389.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: